List of Studies ( Metabolite:Cer 18:1;O2/26:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004167 | AN006917 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST004167 | AN006918 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST004049 | AN006694 | Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads | Macrophages | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST004049 | AN006695 | Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads | Macrophages | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003776 | AN006202 | Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion | Liver | Mouse | Environmental exposure | University of Bonn | LC-MS |
| ST003760 | AN006174 | Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003758 | AN006170 | Untargeted lipidomics of gemcitabine-resistant cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003757 | AN006168 | Untargeted lipidomics of gemcitabine-resistant PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003705 | AN006078 | Lipid Metabolite Profiling of nontuberculous mycobacterial pulmonary disease | Blood | Human | Lung disease | Seoul National University College of Medicine and Hospital | LC-MS |
| ST003702 | AN006074 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO | Liver | Mouse | University of Bonn | LC-MS | |
| ST003694 | AN006061 | FOLFIRINOX effects on lipidomics in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003678 | AN006039 | The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003661 | AN006017 | Lipidomics facilitates the discovery of diagnostic biomarkers in patients with chronic total occlusion during the perioperative period | Blood | Human | Cardiovascular disease | Zhongshan Hospital Fudan University | LC-MS |
| ST003645 | AN005984 | Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer | Cultured cells | Human | Cancer | Universidad Francisco de Vitoria - Hospital 12 de Octubre | LC-MS |
| ST003637 | AN005973 | lomitapide effects on lipidomics | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003629 | AN005962 | Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells | T-cells | Human | Brain disease | Leibniz Institute for Plasma Science and Technology | LC-MS |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003578 | AN005876 | NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesis | Cultured cells | Human | Cancer | Genentech Inc. | FIA-MS |
| ST003528 | AN005796 | Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma | Liver | Mouse | Cancer | University of Utah | LC-MS |
| ST003527 | AN005794 | Combining antibiotics alters the longitudinal maturation of gut microbiota and its short chain fatty acid metabolites in extremely and very preterm infants | Feces | Human | Gastrointestinal disease | Seoul National University | GC-MS/LC-MS |
| ST003514 | AN005770 | Highly reliable LC-MS lipidomics database for efficient human plasma profiling based on NIST SRM 1950 | Blood | Human | Universidad CEU San Pablo | LC-MS | |
| ST003477 | AN005712 | Biocrates Test | Blood | Human | Hannover Medical School | LC-MS | |
| ST003410 | AN005601 | Lipidomics Analysis of ER+ Breast Cancer Cells Treated with Giredestrant and Palbociclib | Cultured cells | Human | Cancer | Genentech Inc. | LC-MS |
| ST003403 | AN005585 | The double-edged role of FASII regulator FabT in Streptococcus pyogenes infection - Metabolomics | Bacterial cells | Streptococcus pyogenes | Bacterial infection | INSERM | LC-MS |
| ST003364 | AN005511 | Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease | Aortic valve tissue | Human | Heart disease | Technical University Dresden | LC-MS |
| ST003364 | AN005512 | Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease | Aortic valve tissue | Human | Heart disease | Technical University Dresden | LC-MS |
| ST003357 | AN005499 | Incorporation of oleate-d9 and elaidate-d17 in sphingolipids in Huh7 cells. | Cultured cells | Human | Atherosclerosis | Salk Institute for Biological Studies | LC-MS |
| ST003341 | AN005475 | Untargeted Lipidomic Profiling of Canine Cancer Cell Lines | Cultured cells | Dog | Cancer | Kojin Therapeutics, Inc. | LC-MS |
| ST003326 | AN005448 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | LC-MS |
| ST003290 | AN005389 | High expression of oleoyl-ACP-hydrolase underpins life-threatening respiratory viral diseases | Lung | Mouse | Viral infection | Peter Doherty Institute for Infection and Immunity | LC-MS |
| ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003130 | AN005133 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal blood | Blood | Mouse | University of Copenhagen | LC-MS | |
| ST003125 | AN005124 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Fetal liver | Liver | Mouse | Maternal immune system activation | University of Copenhagen | LC-MS |
| ST003114 | AN005103 | Lipidomics analyses in model membranes, isolated mitochondria and cellular systems to study how the local lipid environment affects BAX and BAK function during apoptosis. | Mitochondria | Human | Cancer | University of Cologne | LC-MS |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST003090 | AN005054 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST003058 | AN005013 | Spatiotemporal mapping of lipid disturbance in heart injury - Part 2 | Blood | Mouse | Heart injury | National University of Singapore | LC-MS |
| ST002967 | AN004875 | Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002782 | AN004529 | Lipidomics analysis of maternal obesity model - knock out | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002782 | AN004529 | Lipidomics analysis of maternal obesity model - knock out | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002747 | AN004457 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
| ST002747 | AN004457 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
| ST002732 | AN004429 | Impaired metabolism predicts coronary artery calcification in women with systemic lupus erythematosus | Blood | Human | Systemic lupus erythematosus | INSERM | LC-MS |
| ST002724 | AN004415 | Ceramides profile in HeLa overexpressing nSMase2 (SMPD3) | Cultured cells | Human | State University of New York | LC-MS | |
| ST002713 | AN004398 | Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics | Cultured cells | Human | Cancer | University of Colorado Denver | LC-MS |
| ST002691 | AN004364 | MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Untargeted Lipidomics, Reversed-Phase Positive | White adipose | Rat | Georgia Institute of Technology | LC-MS | |
| ST002685 | AN004358 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Brown Adipose Powder - Untargeted Lipidomics, Reversed-Phase Positive | Brown adipose | Rat | Georgia Institute of Technology | LC-MS | |
| ST002678 | AN004350 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Untargeted Lipidomics, Reversed-Phase Positive | Liver | Rat | Georgia Institute of Technology | LC-MS | |
| ST002657 | AN004329 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted Lipidomics, Reversed-Phase Positive | Kidney | Rat | Georgia Institute of Technology | LC-MS | |
| ST002652 | AN004324 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Untargeted Lipidomics, Reversed-Phase Positive | Heart | Rat | Georgia Institute of Technology | LC-MS | |
| ST002637 | AN004309 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Hippocampus Powder - Untargeted Lipidomics, Reversed-Phase Positive | Hippocampus | Rat | Georgia Institute of Technology | LC-MS | |
| ST002631 | AN004303 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Plasma - Untargeted Lipidomics, Reversed-Phase Positive | Blood | Rat | Georgia Institute of Technology | LC-MS | |
| ST002522 | AN004156 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST002505 | AN004127 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002452 | AN004008 | Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations | Brain | Human | Dementia | University of Sydney | LC-MS |
| ST002411 | AN003930 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP negative data) | Intestine | Human | University of California, Davis | LC-MS | |
| ST002400 | AN003908 | Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis | Cultured cells | Human | INSERM | LC-MS | |
| ST002398 | AN003905 | Lipidomics of Tango2 Deficient and Wildtype Zebrafish Muscle Tissue | Muscle | Zebrafish | Myopathy | University of North Carolina at Chapel Hill | LC-MS |
| ST002334 | AN003810 | Phospholipase D3 impact on the endolysosomal lipidome | Cultured cells | Human | Alzheimers disease | VIB-KU Leuven | LC-MS |
| ST002284 | AN003732 | Genetically defined human GBM organoids reveal principles of GBM development and actionable targets | Cultured cells | Human | Cancer | DKFZ | LC-MS |
| ST002283 | AN003730 | The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains | Bone | Human | University of Central Lancashire | LC-MS | |
| ST002283 | AN003731 | The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains | Bone | Human | University of Central Lancashire | LC-MS | |
| ST002243 | AN003661 | Lipidomics analysis of Friedreich's ataxia (FRDA) (part II) | Blood | Human | Friedreichs Ataxia | University of Pennsylvania | LC-MS |
| ST002180 | AN003571 | Global, distinctive and personal changes in molecular and microbial profiles induced by specific fibers in humans (Targeted) | Blood | Human | Stanford University | LC-MS | |
| ST002093 | AN003419 | Lipidomics of High Fat vs Control Mice | Lung | Mouse | Obesity | University of North Carolina at Chapel Hill | LC-MS |
| ST002047 | AN003334 | Lyso-lipid induced oligodendrocytes maturation underlie restoration of optic nerve function | Cultured cells | Rat | Eye disease | University of Miami | LC-MS |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Liver | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Thyroid | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST001950 | AN003174 | Lipidome Alterations Following Mild Traumatic Brain Injury. | Blood | Rat | Traumatic brain injury | Georgia Institute of Technology | LC-MS |
| ST001942 | AN003184 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001936 | AN004932 | Pseudoexfoliation aqueous humor lipidome suggests enrichment of specific pathways | Eye tissue | Human | Pseudoexfoliation syndrome | University of Miami | LC-MS |
| ST001877 | AN003080 | Targeted Sphingolipid analysis of HeLa knockout for expression of GRASP55 | HeLa cells | Human | IBBC, CNR | LC-MS | |
| ST001849 | AN002996 | Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) | Blood | Human | COVID-19 | Washington University in St. Louis | LC-MS |
| ST001789 | AN002901 | Acute metabolomic changes of plasma in response to endurance exercise | Blood | Human | University of California, San Diego | LC-MS | |
| ST001738 | AN002830 | AdipoAtlas: A Reference Lipidome for Human White Adipose Tissue | Adipose tissue | Human | Obesity | University of Leipzig | LC-MS |
| ST001725 | AN002810 | Lipidomics dataset of Danio rerio optic nerve regeneration model | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST001687 | AN002754 | Non-transformed cells respond to fat by inducing glucose metabolism | Liver | Mouse | VIB-KU Leuven Center for Cancer Biology | LC-MS | |
| ST001678 | AN002736 | Quantitative measurements of sphingolipids in Th17 cells before and after the knockdown of UGCG gene (GCS pathway: sphingolipid metabolism) (part-IV) | T-cells | Human | University of Turku | LC-MS | |
| ST001677 | AN002735 | Quantitative targeted measurements of sphingolipids in Th17 cells before and after the triple knockdown of SPTLC1,2,3 genes (SPT, de novo pathway: sphingolipid metabolism) (part-III) | T-cells | Human | University of Turku | LC-MS | |
| ST001675 | AN002733 | Quantitative measurements of ceramides and glycosphingolipids in Th17 and iTreg cells (part-II) | T-cells | Human | University of Turku | LC-MS | |
| ST001673 | AN002731 | Targeted Sphingolipid analysis of HeLa silenced for or overexpressing GOLPH3 or LCS | HeLa cells | Human | École polytechnique fédérale de Lausanne (EPFL) | LC-MS | |
| ST001672 | AN002730 | Targeted Sphingolipid analysis of human Fibroblasts silenced for or overexpressing GOLPH3 | Fibroblast cells | Human | École polytechnique fédérale de Lausanne (EPFL) | LC-MS | |
| ST001632 | AN002667 | Lipidomics of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat | Blood | Rat | Ischemia | Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College | LC-MS |
| ST001632 | AN002667 | Lipidomics of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat | Heart | Rat | Ischemia | Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College | LC-MS |
| ST001442 | AN002410 | Human Optic Nerve Glaucoma and Control Lipidomes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST001420 | AN002375 | Metabolomic analysis of patients with recurrent angina | Blood | Human | Angina | University of California, San Diego | |
| ST001363 | AN002269 | Monophasic lipidomics extraction in cancer cell lines | Hep G2 cells | Human | Cancer | Institute of Genetics and Molecular Medicine | LC-MS |
| ST001345 | AN002239 | C56BL6 WT or IFNARKO BMDM stimulated with different TLRs (part-V) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001344 | AN002238 | C56BL6 WT or MyD88KO BMDM stimulated with different TLRs (part-IV) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001343 | AN002237 | C56BL6 WT or TRIFKO BMDM stimulated with different TLRs (part-III) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001342 | AN002236 | Timecourse of C56BL6 BMDM stimulated with different TLRs (part-I) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001341 | AN002235 | C56BL6 BMDM stimulated with different TLRs W/O acetylated LDL (part-II) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001336 | AN002226 | Effect of high-fat diet and bile acid treatment on serum and tissue lipidomes in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | LC-MS | |
| ST001332 | AN002221 | LCMS lipid and acyl-carnitine analysis | Worms | C. elegans | Environmental exposure | University of Cambridge | LC-MS |
| ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000917 | AN001501 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000916 | AN001495 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000915 | AN001489 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000679 | AN001044 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000617 | AN000947 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, San Diego | LC-MS |
| ST000608 | AN000930 | Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies | Blood | Human | Pacific Northwest National Laboratory | GC-MS/LC-MS | |
| ST000450 | AN000705 | Metabolic features of chronic fatigue syndrome | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, San Diego | LC-MS |
| ST000136 | AN000218 | NIST lipidomics intralaboratory study | Blood | Human | University of Florida | LC-MS | |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST000004 | AN000006 | Lipidomics studies on NIDDK / NIST human plasma samples | Blood | Human | LIPID MAPS | LC-MS |
